CAREDX, INC. Interest Expense
CAREDX, INC. (CDNA) reported Interest Expense of $568.00 thousand for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2016-11-14
- CAREDX, INC. interest expense for the quarter ending 2016-09-30 was $568.00K, a 126.29% increase year-over-year.
- CAREDX, INC. interest expense for the quarter ending 2016-06-30 was $526.00K, a 105.47% increase year-over-year.
- CAREDX, INC. interest expense for the quarter ending 2016-03-31 was $266.00K, a 67.84% decline year-over-year.
- CAREDX, INC. interest expense for the quarter ending 2015-09-30 was $251.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month |
|---|---|---|---|
| 2016-09-30 | $568.00K 10-Q · filed 2016-11-14 | $1.09M derived: sum of 2 quarters · filed 2016-11-14 | $1.35M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $526.00K 10-Q · filed 2016-08-22 | $783.00K 10-Q · filed 2016-08-22 | |
| 2016-03-31 | $266.00K 10-Q · filed 2016-05-16 | ||
| 2015-09-30 | $251.00K 10-Q · filed 2016-11-14 | $507.00K derived: sum of 2 quarters · filed 2016-11-14 | $1.33M 10-Q · filed 2016-11-14 |
| 2015-06-30 | $256.00K 10-Q · filed 2016-08-22 | $1.08M 10-Q · filed 2016-08-22 | |
| 2015-03-31 | $827.00K 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |